Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Obesity11722 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A01139 | 34857248 | Clin Nutr ESPEN | Effect of l-carnitine supplementation on liver fat content and cardiometabolic indices in overweight/obese women with polycystic ovary syndrome: A randomized controlled trial. | 2021 | Details |
| A01140 | 34857244 | Clin Nutr ESPEN | High prevalence of hepatic steatosis and hepatic fibrosis in patients with type 2 diabetes mellitus. | 2021 | Details |
| A01141 | 34857059 | J Dev Orig Health Dis | Maternal high-fat diet consumption programs male offspring to mitigate complications in liver regeneration. | 2021 | Details |
| A01143 | 34856895 | Curr Protein Pept Sci | Soybean β-Conglycinin: Structure Characteristic, Allergenicity, Plasma Lipid-Controlling, Prevention of Obesity and Non-alcoholic Fatty Liver Disease. | 2021 | Details |
| A01146 | 34855640 | Chin Med J (Engl) | Non-alcoholic steatohepatitis and risk of hepatocellular carcinoma. | 2021 | Details |
| A01151 | 34853949 | Handb Exp Pharmacol | Inter-Organ Crosstalk in the Development of Obesity-Associated Insulin Resistance. | 2021 | Details |
| A01152 | 34853313 | Nat Commun | GP73 is a TBC-domain Rab GTPase-activating protein contributing to the pathogenesis of non-alcoholic fatty liver disease without obesity. | 2021 | Details |
| A01153 | 34851748 | Can J Physiol Pharmacol | The anti-anginal ranolazine does not confer beneficial actions against hepatic steatosis in male mice subjected to high-fat diet and streptozotocin-induced type 2 diabetes. | 2021 | Details |
| A01156 | 34850445 | J Gastroenterol Hepatol | The microbial metabolome in metabolic-associated fatty liver disease. | 2021 | Details |
| A01157 | 34849373 | Front Phys | Feasibility of Hepatic Fat Quantification Using Proton Density Fat Fraction by Multi-Echo Chemical-Shift-Encoded MRI at 7T. | 2021 | Details |
| A01160 | 34848839 | Exp Mol Med | Roles of IκB kinases and TANK-binding kinase 1 in hepatic lipid metabolism and nonalcoholic fatty liver disease. | 2021 | Details |
| A01164 | 34847883 | BMC Gastroenterol | Total polyunsaturated fatty acid intake and the risk of non-alcoholic fatty liver disease in Chinese Han adults: a secondary analysis based on a case-control study. | 2021 | Details |
| A01167 | 34847213 | Food Funct | Curcumin supplementation improves biomarkers of oxidative stress and inflammation in conditions of obesity, type 2 diabetes and NAFLD: updating the status of clinical evidence. | 2021 | Details |
| A01170 | 34843158 | Liver Int | Causal effects from non-alcoholic fatty liver disease on kidney function: A Mendelian randomization study. | 2021 | Details |
| A01173 | 34841290 | Cell Rep Med | Electronic health record-based genome-wide meta-analysis provides insights on the genetic architecture of non-alcoholic fatty liver disease. | 2021 | Details |
| A01174 | 34840719 | Ther Adv Endocrinol Metab | NAFLD in type 1 diabetes: overrated or underappreciated? | 2021 | Details |
| A01178 | 34838723 | Clin Gastroenterol Hepatol | Systematic Review and Meta-analysis: The Role of Diet in the Development of Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A01179 | 34838715 | Mol Metab | A novel role of CRTC2 in promoting nonalcoholic fatty liver disease. | 2021 | Details |
| A01182 | 34836382 | Nutrients | The Interplay of Vitamin D Deficiency and Cellular Senescence in The Pathogenesis of Obesity-Related Co-Morbidities. | 2021 | Details |
| A01183 | 34836332 | Nutrients | Impact of Genetic Polymorphism on Response to Therapy in Non-Alcoholic Fatty Liver Disease. | 2021 | Details |
| A01184 | 34836318 | Nutrients | Early-Life Exposure to Famine and Risk of Metabolic Associated Fatty Liver Disease in Chinese Adults. | 2021 | Details |
| A01188 | 34835949 | Nutrients | Effects of Lingonberry (Vaccinium vitis-idaea L.) Supplementation on Hepatic Gene Expression in High-Fat Diet Fed Mice. | 2021 | Details |
| A01191 | 34835410 | Microorganisms | Polyclonal Aptamers for Specific Fluorescence Labeling and Quantification of the Health Relevant Human Gut Bacterium Parabacteroides distasonis. | 2021 | Details |
| A01194 | 34831201 | Cells | Lipid Metabolism Disorders in the Comorbid Course of Nonalcoholic Fatty Liver Disease and Chronic Obstructive Pulmonary Disease. | 2021 | Details |
| A01195 | 34831031 | Cells | Bile Acid Receptors and the Gut-Liver Axis in Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A01196 | 34830997 | Cancers (Basel) | Hepatocellular Carcinoma in Non-Alcoholic Fatty Liver Disease: From Epidemiology to Diagnostic Approach. | 2021 | Details |
| A01201 | 34829968 | Biomedicines | The Role of Neuropeptide Y in Adipocyte-Macrophage Crosstalk during High Fat Diet-Induced Adipose Inflammation and Liver Steatosis. | 2021 | Details |
| A01202 | 34829926 | Biomedicines | Non-Alcoholic Fatty Liver Disease (NAFLD) and Potential Links to Depression, Anxiety, and Chronic Stress. | 2021 | Details |
| A01206 | 34829779 | Biomedicines | Sex-Dependent Effects of Eicosapentaenoic Acid on Hepatic Steatosis in UCP1 Knockout Mice. | 2021 | Details |
| A01208 | 34829565 | Antioxidants (Basel) | Anti-NAFLD Effect of Djulis Hull and Its Major Compound, Rutin, in Mice with High-Fat Diet (HFD)-Induced Obesity. | 2021 | Details |
| A01211 | 34828697 | Children (Basel) | Association between Hepatic Steatosis and Obstructive Sleep Apnea in Children and Adolescents with Obesity. | 2021 | Details |
| A01213 | 34828259 | Genes (Basel) | Aberrant DNA Methylation Mediates the Transgenerational Risk of Metabolic and Chronic Disease Due to Maternal Obesity and Overnutrition. | 2021 | Details |
| A01215 | 34827579 | Biomolecules | Effect of Bariatric Surgery on Metabolic Diseases and Underlying Mechanisms. | 2021 | Details |
| A01219 | 34825068 | Biochem Biophys Rep | Metformin treatment reverses high fat diet- induced non-alcoholic fatty liver diseases and dyslipidemia by stimulating multiple antioxidant and anti-inflammatory pathways. | 2021 | Details |
| A01220 | 34823548 | J Transl Med | CD226 knockout alleviates high-fat diet induced obesity by suppressing proinflammatory macrophage phenotype. | 2021 | Details |
| A01224 | 34822647 | Vet Sci | Protective and Therapeutic Effects of Orlistat on Metabolic Syndrome and Oxidative Stress in High-Fat Diet-Induced Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) in Rats: Role on Nrf2 Activation. | 2021 | Details |
| A01227 | 34822395 | Metabolites | Aqueous Metabolite Trends for the Progression of Nonalcoholic Fatty Liver Disease in Female Bariatric Surgery Patients by Targeted 1H-NMR Metabolomics. | 2021 | Details |
| A01229 | 34821899 | Food Funct | Maternal sucralose exposure induces Paneth cell defects and exacerbates gut dysbiosis of progeny mice. | 2021 | Details |
| A01233 | 34819792 | Saudi Pharm J | Cold-pressed raspberry seeds oil ameliorates high-fat diet triggered non-alcoholic fatty liver disease. | 2021 | Details |
| A01234 | 34819740 | Clin Exp Gastroenterol | Nonalcoholic Fatty Liver Disease and Chronic Kidney Disease: A Review of Links and Risks. | 2021 | Details |
| A01236 | 34818372 | PLoS One | Subclinical steatohepatitis and advanced liver fibrosis in health examinees with nonalcoholic fatty liver disease (NAFLD) in 10 South Korean cities: A retrospective cross-sectional study. | 2021 | Details |
| A01237 | 34818080 | Metab Syndr Relat Disord | Increased Serum Pentraxin 3 Is Associated with Prediabetes and Type 2 Diabetes in Obese Patients with Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A01240 | 34816913 | Rev Assoc Med Bras (1992) | Muscle mass and cellular membrane integrity assessment in patients with nonalcoholic fatty liver disease. | 2021 | Details |
| A01242 | 34816355 | Obes Surg | Routine Versus Selective Liver Biopsy During Bariatric Surgery: Postoperative Outcomes and Preoperative Predictors of NASH. | 2021 | Details |
| A01248 | 34814419 | Zhonghua Liu Xing Bing Xue Za Zhi | [Analysis on influencing factors for nonalcoholic fatty liver disease in Jinchang cohort]. | 2021 | Details |
| A01253 | 34813997 | Biomed Pharmacother | SP-1154, a novel synthetic TGF-β inhibitor, alleviates obesity and hepatic steatosis in high-fat diet-induced mice. | 2021 | Details |
| A01256 | 34813496 | Physiol Int | Effect of vanillic acid and exercise training on fatty liver and insulin resistance in rats: Possible role of fibroblast growth factor 21 and autophagy. | 2021 | Details |
| A01258 | 34813249 | Arch Argent Pediatr | [Obesity-fatty liver: the role of the pediatrician]. | 2021 | Details |
| A01260 | 34811578 | Handb Exp Pharmacol | NAFLD and NASH: The Metabolically Diseased Liver. | 2021 | Details |
| A01261 | 34810377 | Saudi J Gastroenterol | Association of metabolic traits with occurrence of nonalcoholic fatty liver disease-related hepatocellular carcinoma: A systematic review and meta-analysis of longitudinal cohort studies. | 2022 | Details |
| A01264 | 34809412 | Endocrinol Metab (Seoul) | The Leg Fat to Total Fat Ratio Is Associated with Lower Risks of Non-Alcoholic Fatty Liver Disease and Less Severe Hepatic Fibrosis: Results from Nationwide Surveys (KNHANES 2008-2011). | 2021 | Details |
| A01267 | 34808500 | Biochem Biophys Res Commun | Endoplasmic reticulum stress increases LECT2 expression via ATF4. | 2021 | Details |
| A01279 | 34803916 | Front Endocrinol (Lausanne) | Sestrin2 as a Potential Target for Regulating Metabolic-Related Diseases. | 2021 | Details |
| A01281 | 34803499 | Int J Biol Sci | CD38 Deficiency Protects Mice from High Fat Diet-Induced Nonalcoholic Fatty Liver Disease through Activating NAD+/Sirtuins Signaling Pathways-Mediated Inhibition of Lipid Accumulation and Oxidative Stress in Hepatocytes. | 2021 | Details |
| A01285 | 34803123 | Endocr J | Prediction and validation of nonalcoholic fatty liver disease by fatty liver index in a Japanese population. | 2021 | Details |
| A01286 | 34802660 | Clin Liver Dis | Endoscopic Bariatric Interventions in Patients with Chronic Liver Disease. | 2021 | Details |
| A01299 | 34797530 | Rheumatol Ther | Psoriatic Arthritis: The Influence of Co-morbidities on Drug Choice. | 2021 | Details |
| A01308 | 34794234 | Biomed Pharmacother | Saroglitazar and Hepano treatment offers protection against high fat high fructose diet induced obesity, insulin resistance and steatosis by modulating various class of hepatic and circulating lipids. | 2021 | Details |
| A01334 | 34786161 | World J Hepatol | Transition of an acronym from nonalcoholic fatty liver disease to metabolic dysfunction-associated fatty liver disease. | 2021 | Details |
| A01336 | 34785385 | Clin Res Hepatol Gastroenterol | Trans-anethole attenuates diet-induced nonalcoholic steatohepatitis through suppressing TGF-β-mediated fibrosis. | 2021 | Details |
| A01339 | 34783554 | J Agric Food Chem | Novel Sesquiterpene Glycoside from Loquat Leaf Alleviates Type 2 Diabetes Mellitus Combined with Nonalcoholic Fatty Liver Disease by Improving Insulin Resistance, Oxidative Stress, Inflammation, and Gut Microbiota Composition. | 2021 | Details |
| A01340 | 34783191 | Hepatol Commun | Predicting Liver-Related Outcomes in People With Nonalcoholic Fatty Liver Disease: The Prognostic Value of Noninvasive Fibrosis Tests. | 2021 | Details |
| A01344 | 34780785 | Exp Cell Res | MicroRNA-22 inhibition promotes the development of atherosclerosis via targeting interferon regulator factor 5. | 2021 | Details |
| A01347 | 34779535 | Hepatology | Effect of diabetes medications and glycemic control on risk of hepatocellular cancer in patients with nonalcoholic fatty liver disease. | 2021 | Details |
| A01348 | 34779464 | Food Funct | MUFA in metabolic syndrome and associated risk factors: is MUFA the opposite side of the PUFA coin? | 2021 | Details |
| A01349 | 34779413 | J Clin Invest | Controversies surrounding peripheral cannabinoid receptor 1 in fatty liver disease. | 2021 | Details |
| A01353 | 34777740 | Ther Adv Chronic Dis | The association between NAFLD and risk of chronic kidney disease: a cross-sectional study. | 2021 | Details |
| A01357 | 34776827 | Food Nutr Res | Weissella cibaria MG5285 and Lactobacillus reuteri MG5149 attenuated fat accumulation in adipose and hepatic steatosis in high-fat diet-induced C57BL/6J obese mice. | 2021 | Details |
| A01360 | 34774753 | Mol Ther | An RNAi therapeutic targeting hepatic DGAT2 in a genetically obese mouse model of nonalcoholic steatohepatitis. | 2021 | Details |
| A01365 | 34774104 | Trials | Effects of naringenin supplementation in overweight/obese patients with non-alcoholic fatty liver disease: study protocol for a randomized double-blind clinical trial. | 2021 | Details |
| A01366 | 34773939 | Clin Exp Pediatr | Effects of probiotics combined with dietary and lifestyle modification on clinical, biochemical, and radiological parameters in obese children with NASH/NAFLD: a randomized clinical trial. | 2021 | Details |
| A01369 | 34773093 | Eur J Clin Nutr | Role of high-salt diet in non-alcoholic fatty liver disease: a mini-review of the evidence. | 2021 | Details |
| A01374 | 34769488 | Int J Mol Sci | The Roles of Carbohydrate Response Element Binding Protein in the Relationship between Carbohydrate Intake and Diseases. | 2021 | Details |
| A01377 | 34769060 | Int J Mol Sci | Pathophysiological Molecular Mechanisms of Obesity: A Link between MAFLD and NASH with Cardiovascular Diseases. | 2021 | Details |
| A01378 | 34768942 | Int J Mol Sci | In a Prediabetic Model, Empagliflozin Improves Hepatic Lipid Metabolism Independently of Obesity and before Onset of Hyperglycemia. | 2021 | Details |
| A01380 | 34768539 | J Clin Med | What Do We Know about Inequalities in NAFLD Distribution and Outcomes? A Scoping Review. | 2021 | Details |
| A01381 | 34768440 | J Clin Med | Prothrombotic and Inflammatory Markers in Elderly Patients with Non-Alcoholic Hepatic Liver Disease before and after Weight Loss: A Pilot Study. | 2021 | Details |
| A01384 | 34765249 | Curr Health Sci J | Contribution of Modern Echocardiographic Techniques in the Detection of Subclinical Heart Dysfunction in Young Adults with Non-Alcoholic Fatty Liver Disease. | 2021 | Details |
| A01392 | 34762779 | Arch Endocrinol Metab | Acoustic radiation force impulse elastography and liver fibrosis risk scores in severe obesity. | 2021 | Details |
| A01395 | 34762106 | JAMA | Association of Bariatric Surgery With Major Adverse Liver and Cardiovascular Outcomes in Patients With Biopsy-Proven Nonalcoholic Steatohepatitis. | 2021 | Details |
| A01399 | 34760965 | Hepatobiliary Surg Nutr | Accuracy of non-invasive liver stiffness measurement and steatosis quantification in patients with severe and morbid obesity. | 2021 | Details |
| A01400 | 34759828 | Front Pharmacol | Hepatopathy Associated With Type 1 Diabetes: Distinguishing Non-alcoholic Fatty Liver Disease From Glycogenic Hepatopathy. | 2021 | Details |
| A01403 | 34758930 | Arch Pediatr | The role of nutrition in non-alcoholic fatty liver disease treatment in obese children. | 2021 | Details |
| A01406 | 34758326 | Cell Rep | m6A mRNA methylation-directed myeloid cell activation controls progression of NAFLD and obesity. | 2021 | Details |
| A01407 | 34757877 | Pediatr Ann | Approach to Pediatric Obesity and Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A01410 | 34757198 | Clin Gastroenterol Hepatol | Longitudinal Changes in MR Elastography-based Biomarkers in Obese Patients Treated with Bariatric Surgery. | 2021 | Details |
| A01413 | 34757046 | Mol Metab | Pleiotropic actions of IP6K1 mediate hepatic metabolic dysfunction to promote nonalcoholic fatty liver disease and steatohepatitis. | 2021 | Details |
| A01417 | 34755544 | J Am Heart Assoc | Nonalcoholic Fatty Liver Disease and Risk of Heart Failure Among Medicare Beneficiaries. | 2021 | Details |
| A01430 | 34749893 | Nurs Clin North Am | Obesity and Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A01444 | 34743657 | Adipocyte | Association of cell death mechanisms and fibrosis in visceral white adipose tissue with pathological alterations in the liver of morbidly obese patients with NAFLD. | 2021 | Details |
| A01446 | 34742934 | Arch Biochem Biophys | The probiotic effects of AB23A on high-fat-diet-induced non-alcoholic fatty liver disease in mice may be associated with suppressing the serum levels of lipopolysaccharides and branched-chain amino acids. | 2021 | Details |
| A01459 | 34740573 | Metabolism | Insights into the molecular targets and emerging pharmacotherapeutic interventions for nonalcoholic fatty liver disease. | 2021 | Details |
| A01460 | 34740314 | Mol Med | Nuclear receptors: a bridge linking the gut microbiome and the host. | 2021 | Details |
| A01462 | 34739937 | Nutrition | Comparison of bioelectrical impedance analysis, mass index, and waist circumference in assessing risk for non-alcoholic steatohepatitis. | 2021 | Details |
| A01465 | 34737604 | J Inflamm Res | Curcumae Ameliorates Diethylnitrosamine-Induced Hepatocellular Carcinoma via Alteration of Oxidative Stress, Inflammation and Gut Microbiota. | 2021 | Details |
| A01468 | 34736591 | Pediatr Clin North Am | Pediatric Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A01470 | 34736334 | Ceska Gynekol | Conservative possibilities influencing PCOS syndrome - the importance of nutrition. | 2021 | Details |
| A01478 | 34733762 | J Lasers Med Sci | The Effect of Laser Therapy Along With Mediterranean Diet Versus Mediterranean Diet Only on Older Adults With Non-alcoholic Fatty Liver Disease: A Randomized Clinical Trial. | 2021 | Details |
| A01479 | 34732369 | Pharmacol Res | Ajugol enhances TFEB-mediated lysosome biogenesis and lipophagy to alleviate non-alcoholic fatty liver disease. | 2021 | Details |
| A01483 | 34729904 | Obes Rev | Gut microbiota and related metabolites in the pathogenesis of nonalcoholic steatohepatitis and its resolution after bariatric surgery. | 2021 | Details |